Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 315834011000036111 | efalizumab 125 mg injection [4 vials] (&) inert substance diluent [4 x 1.32 mL syringes], 1 pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 315835011000036110 | efalizumab 125 mg injection [4 x 125 mg vials] (&) inert substance diluent [4 x 1.32 mL syringes], 1 pack (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| efalizumab 125 mg injection [4 vials] (&) inert substance diluent [4 x 1.32 mL syringes], 1 pack | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| efalizumab 125 mg injection [4 vials] (&) inert substance diluent [4 x 1.32 mL syringes], 1 pack | has MPUU | efalizumab 125 mg injection, vial | true | Inferred relationship | Some | 1 | |
| efalizumab 125 mg injection [4 vials] (&) inert substance diluent [4 x 1.32 mL syringes], 1 pack | has MPUU | inert substance diluent, 1.32 mL syringe | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Raptiva (4 x 125 mg vials, 4 x 1.32 mL inert diluent syringes), 1 pack | Is a | True | efalizumab 125 mg injection [4 vials] (&) inert substance diluent [4 x 1.32 mL syringes], 1 pack | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR